W La Revue canadienne de psychiatrie, vol 54, no 7, juillet 2009 452 Objective: To determine the characteristics of diagnostic conversion from unipolar depression to bipolar depression in psychiatric outpatients, and to compare the profiles of the 2 groups of patients.
T here is evidence that the distinction between major depressive disorder and BD is a therapeutic imperative. Treatments for the 2 disorders are substantially different and treating patients having BD with unipolar therapy algorithms may lead to unfavourable outcomes. ADs may induce manic or hypomanic swings or cycle acceleration. 1 Depression is often the first manifestation of abnormal mood in BD. In a survey 2 of 500 patients, 33% reported depressive symptoms as the most common initial symptom. In addition, although manic episodes are the distinguishing diagnostic feature of BD, on average BD I patients spend 3-fold as much time in a depressed state than in a manic or hypomanic state. 3 Longitudinal studies have shown that conversion from unipolar to BD is not uncommon. A 15-year prospective study of 74 patients hospitalized for unipolar depression found that 27% had developed one or more distinct periods of hypomania and another 19% had at least one episode of full bipolar mania. 4 Delayed recognition of BD appears to be common, even in more recent investigations. 5, 6 Results of some studies raised the issue of phenomenological differences between these 2 depressive syndromes as clinical signatures of bipolar depression. In bipolar depression, a greater prevalence of atypical features, such as hypersomnia or hyperphagia, was reported by some studies. 7 Likewise, a greater prevalence of melancholic symptoms among patients with bipolar depression has been identified. 8 Also, irritability, 9,10 anger, 11, 12 and subthreshold mixed symptoms, such as overactivity 13 and psychosis, 14 have also been associated with bipolar depression. Perlis et al 15 reported in 2006 that bipolar depression was associated with a family history of BD, an earlier age of onset, a greater previous number of depressive episodes, and 8 individual symptom items on the Montgomery-Asberg Depression Rating Scale and the Hamilton Anxiety Rating Scale. A recent study 16 in China found that the ratio of female patients in the bipolar group was lower than in the recurrent depression group, and patients with bipolar depression had more recurrent depressive episodes, lower response rate to ADs, and a younger age when they first had a depressive episode (29. 
Methods
This is a case-control study in which outpatients newly diagnosed with unipolar depression with subsequent bipolar switch were matched with patients whose diagnosis remain unipolar depression throughout the period of follow-up and then compared for potential sociodemographic and clinical variables. Data were obtained from case records and clinical interview of the identified patients using the SCID-I for diagnosis verification of unipolar depression and bipolar switch.
Consecutive samples of outpatients newly registered in the outpatient psychiatric clinic of PYNEH from June 1, 1994, to December 31, 1999, who received a first diagnosis of depressive episode with subsequent diagnostic conversion to BD in the longitudinal course of follow-up were identified and classified as subjects for our study.
Identity of the outpatients newly registered in the psychiatric unit of PYNEH during the period under study was retrieved using the Clinical Data Analysis and Reporting System and the Clinical Management System. Within this sample, those who died, dropped out, or transferred to other sectors for follow-up before December 31, 2007, were excluded, to ensure a regular length of follow-up of at least 8 years.
Patients were also excluded from recruitment if they had a previous history of depression treated at the private sector, had past history of (un)treated (hypo)manic symptoms, and already received a diagnosis of BD at first presentation, or had concomitant diagnosis of schizophrenia, dementia, or mental retardation (because their cognitive impairment may affect the accuracy of the SCID-I results).
For each case, one surviving control subject was matched from the remaining sample of patients presenting in the same year with first-episode untreated unipolar depression, and whose diagnosis maintained unipolar depression without polarity conversion throughout the same period of follow-up until December 31, 2007. Each control subject identified was then interviewed using the SCID-I to ensure the diagnosis of unipolar depression before recruitment into analysis. Data collection was further substantiated with collateral information from significant others. Control subjects with a SCID-I result inconsistent with unipolar course would be excluded and another control subject identified.
Variables in the following 3 aspects were explored. 
Clinical Variables
These included age at presentation of the depressive illness, presence of psychotic symptoms throughout the course of illness (delusions or hallucinations or both), lifetime history of suicide and (or) aggressive attempts, age at first attempt, number of attempts, atypical features (hypersomnia or hyperphagia or both), psychomotor retardation and agitation, anxiety features, obsessive-compulsive features, hypochondriasis, postpartum onset, presence of Axis II disorders, eating disorder or distorted body image, inadequate response to treatment, family history of mental illness, family history of bipolar affective disorder (from case records and from the SCID), and presence of chronic physical illnesses (requiring regular follow-up and treatment). The time to remission for the index of depression was not investigated in this study because sufficient retrospective data to judge remission or not may not be present in all of the case records. If a prospective study is carried out, an instrument such as the Hamilton Rating Scale for Depression can be applied to score the presence and severity of residual symptoms in a standardized way to define remission.
Treatment Variables
Treatment variables included the use of electroconvulsive therapy during hospitalization or outpatient follow-up period, total number of different ADs used in the first 5 years after presentation, average number of clinic follow-ups per year in the first 5 years after presentation, number of psychiatric admissions if any, and average length of inpatient stay and auxiliary services provided by related disciplines (medical social worker, occupational therapist, community psychiatric nurse, clinical psychologist, or physiotherapist).
The instruments used included the SCID-I and Clinical Global Impressions for measurement of the presence of inadequate response to treatment 1 year after presentation. The scale includes 3 items: severity of illness, global improvement, and efficacy index.
A rating of 3 to 7 for the first item (mildly ill, moderately ill, markedly ill, severely ill, or extremely ill), a rating of 4 to 7 for the second item (no change, minimally worse, much worse, or very much worse), and a rating of 13 to 16 for the third item (therapeutic effect: unchanged or worse) at 1 year after presentation are regarded as persistence or deterioration of the initial symptoms.
This project was approved by the Ethics Committee of PYNEH. Permission was also given by the Chief of Service of PYNEH to interview the patients and examine the clinical records of the subjects and control subjects. All patients gave written informed consent.
Results
There were 823 newly diagnosed first-episode untreated subjcets with unipolar depression registered in outpatient psychiatric clinic of PYNEH during the specified period who maintained outpatient clinic follow-up until at least December 31, 2007. Their case records were reviewed to identify patients having diagnostic conversion to bipolar affective disorder during the longitudinal course of follow-up, which were then labeled as cases. Eighty-eight subjects were identified, of which 42 (47.7%) were men and 46 (52.3%) were women. The male to female ratio was 0.91:1. Fifty subjects (56.8%) showed hypomanic switch, 37 (42.0%) showed manic switch, and 1 (1.1%) showed a switch to mixed symptoms. Subjects classified as hypomanic, manic, or mixed switch were considered as one group for analysis and in the following were referred as bipolar switch or subjects.
The mean age at bipolar switch for the 88 subjects was 37.58 years (SD 5.321, range 32 to 53). The mean age at bipolar switch in male subjects was 35.52 years (SD 4.341) and in female subjects was 39.46 years (SD 5.480). The sex difference in age at bipolar switch was statistically significant (t = 3.933, df = 86, P = 0.025). Most bipolar switches occurred in the group aged 30 to 39 years, both for male and female subjects. Six of the hypomanic switch cases showed further switch to a manic episode of 5 months to 47 months after the initial hypomanic switch.
The time interval from presentation of depressive symptoms to bipolar switch ranged from 1 month to 134 months. The mean was 58.13 months (SD 29.443, 95% CI 51.89 to 64.36) and the median was 55 months. The mean time from presentation to bipolar switch in men was 58.24 months (SD 24.665) and in women was 58.02 months (SD 33.491). The sex difference in time from presentation to bipolar switch was insignificant. Bipolar switch peaked in the fourth and fifth years after presentation. At 55 months, 50% of the cases had shown bipolar switch. A survival curve of the time from presentation to bipolar switch is shown as follows (Figure 1 ).
Among the 88 subjects in this sample, all were receiving at least one AD in the latest follow-up just before bipolar switch. SSRIs were the most common class, making up nearly one-half of the sample. The second class was serotonin noradrenaline reuptake inhibitors, which was essentially venlafaxine (Effexor) in all cases in this study. All control subjects were prescribed one or more types of AD during the length of follow-up period.
Not all subjects received mood stabilizer(s) after diagnosis of bipolar switch; 4 of the 88 subjects had just the index AD stopped with no addition of mood stabilizers and remained symptom-free in the subsequent course of follow-up. The time interval from bipolar switch to the addition of mood stabilizer(s) ranged from 0 days (91.7% of the cases) to 1469 days (about 4.02 years after diagnosis). Valproate sodium was the most commonly used, followed by lithium carbonate, carbamazepine, and then lamotrigine.
From univariate conditional logistic regression analysis, 7 variables were found to have a P value of less than 0.05 (Table 1) . These included sex, mean age at presentation of depression, psychotic symptoms, family history of bipolar affective disorder (from the SCID-I), mean total number of different types of ADs used in the first 5 years after presentation, mean number of clinic follow-ups per year for the first 5 years, and psychiatric admissions during follow-up period. A chi-square test was used for categorical data analysis and a Student t test was used for continuous (dimensional) measures.
Mean age at presentation for the 88 subjects was earlier (aged 34.00 years, SD 11.783, range 25 to 49) than the control subjects (aged 39.17 years, SD 12.123, range 24 to 56), and the difference was statistically significant (P = 0.005). More subjects presented when aged 37 years and younger, when compared with the control subjects (÷ 2 = 13.262, df = 1, P < 0.05; OR 8.135, 95% CI 4.790 to 16.968). For the subjects, the men presented at a statistically significantly earlier age than the women (aged 31.05 years, compared with 36.70 years, P = 0.021), accounting for the smaller mean age at bipolar switch for the men (aged 35.52 years) than the women (aged 39.46 years), while the time interval from presentation to bipolar switch showed no statistically significant difference between the 2 sexes.
There is no statistically significant difference between the subjects and control subjects for atypical features (hypersomnia or hyperphagia; P = 0.70) and psychomotor retardation (P = 0.30). In the treatment aspect, 3 subjects (3.4%) had a history of receiving electroconvulsive therapy, compared with 2 control subjects (2.3%). The difference was also statistically insignificant (P = 0.65). These variables with a P value of greater than 0.05 were not shown in Table 1 .
Multivariate conditional logistic regression analysis was used to assess the simultaneous influence of different variables on the risk of diagnostic conversion from unipolar depression to BD. In the final model, 4 factors were found to be statistically significant, namely, sex, mean age at presentation of the depressive illness at a cut-off age of 37 years, family history of bipolar affective disorder (from the SCID), and mean total number of different types of ADs used in the first 5 years after presentation at a cut-off of 3. The final model predicted 81.8% of the subjects with diagnostic conversion from unipolar depression to BD and 76.1% of the subjects whose diagnosis maintained unipolar depression throughout the period of follow-up. The overall predication rate was 79.0%. The model explained 40.7% of the variance (Cox and Snell R 2 = 0.407). The Hosmer and Lemeshow test result was statistically insignificant (÷ 2 = 3.905, df = 7, P = 0.79), indicating the model is a good-fitting one.
Three factors, namely, psychotic symptoms, mean number of clinic follow-ups per year for the first 5 years, and psychiatric admissions during the follow-up period were no longer statistically significant after the multivariate conditional logistic regression analysis. This can be explained by the possible correlation among these factors with the total number of different types of ADs used in the first 5 years after presentation, all indicating a greater clinical severity of the depressive illness.
Discussion
This is the first local study comparing the sociodemographic and clinical characteristics of bipolar depression and unipolar depression patients. Subjects with bipolar depression referred to those who showed polarity conversion to increase the homogeneity of the sample. From previous studies, 20, 21 the time elapsed from presentation of unipolar depression to diagnostic conversion ranged from 6.2 to 8.0 years. Therefore, recruitment was designed to start from June 1, 1994, to December 31, 1999, to ensure a follow-up period of at least 8 years from December 31, 1999, to December 31, 2007, for both the subjects and control subjects. This aims at decreasing the possibility of the control subjects potentially developing bipolar depression, having not yet shown diagnostic switch, which would introduce inaccuracies in the comparative analysis. Although a retrospective review performed more than 8 years later would be more preferable, this would compromise the duration of case recruitment, further restricting the sample size as PYNEH was opened in 1994. A balance between the duration of recruitment and period of follow-up has been strived to achieve a substantial length of review for diagnostic conversion and to maximize the sample size as far as possible. Also, control subjects, matched for subjects first presented in 1994, had the maximum follow-up length of 13 years instead of 8 years, during which they maintained a unipolar course.
The issue of AD-induced mania was not investigated in this study. To study this, a well-designed prospective study, for example, a randomized controlled trial, can be carried out to identify the risk factors.
Among the 823 new subjects of unipolar depression registered during the specified period and maintained outpatient The finding that the bipolar group presented at a significantly earlier age, compared with the unipolar group echoed foreign data. The difference in mean age at presentation is 5.17 years in our study, as compared with 6 years reported in one study 23 and 8 years in another. 15 An age cut-off of 37 years was chosen in our study because the mean age at presentation for the subjects and control subjects were found to be 34.00 and 39.17 years, respectively. Different stepwise cut-offs from ages 35 to 39 years, at an interval of 1 year, were then used for data reanalysis to identify the youngest age below which statistically more bipolar subjects had their illness presentation. It was then found that when an age at presentation of younger than 37 years was used to categorize the subjects and control subjects, the difference was statistically significant (P < 0.05).
Cases with bipolar switch were statistically more likely to be prescribed 3 or more different types of ADs in the first 5 years, compared with the control subjects who were statistically more likely to be prescribed none, 1, or 2 ADs during the same period. This correlated to the figure quoted by Prakash S Masand 24 in 2007 that one of the clues to bipolar illness is lack of response to adequate trials of at least 3 different ADs. A postulation of this could be the poorer control of symptoms leading to trial of more types of medications.
Substance and (or) alcohol misuse was not found as a statistically significant factor in our study, in contrast to other previous studies. This could be because unipolar depression subjects with comorbid substance and (or) alcohol misuse at onset (which was clinically more important than the mood disorder) had been given the latter as the principal or primary diagnosis, and therefore subsequently excluded from entry into our study.
From the results of a family history of mental illnesses, differences between subjects and control subjects for family history of bipolar affective disorder became statistically significant when the information obtained from the SCID-I was also taken into account in addition to the information obtained from the case records. This is because the presence or absence of family history of mental illnesses was routinely asked for in the first psychiatric consultation, but might not have been repeatedly requested in subsequent follow-ups. As a result, patients whose family members developed bipolar affective disorder and other mental illnesses after their first presentation might have been missed and not considered. This reflects the importance of exploring clinical parameters regularly at intervals, as this would have implications as a clinical signature for the index patient. Family history of mental illnesses is not a static parameter and may change over time.
In conclusion, there is no particular sex predisposed for diagnostic conversion to bipolarity. Therefore, clinical vigilance is important in the possibility of development of bipolar 
Limitations
This is a retrospective study and data collection was based on a retrospective review of case records, which might be incomplete. The severity of various depressive and anxiety domains could not be accurately quantified retrospectively. Only clinical parameters with numerical values, and those in which the presence or absence were routinely documented in case records, were used for comparison and statistical analysis. Therefore, melancholia, which was not an item regularly mentioned in the follow-up records, could not be studied in this research. Given a prospective study, measures can be considered to rate the severity of psychomotor disturbances as an estimate to distinguish melancholia cases.
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Résumé : Une étude cas-témoin de la dépression bipolaire, comparée avec la dépression unipolaire dans un hôpital régional de Hong Kong Objectif : Déterminer les caractéristiques de la conversion diagnostique de la dépression unipolaire à la dépression bipolaire chez des patients psychiatriques externes, et comparer les profils des 2 groupes de patients.
Méthode :
Il s'agit d'une étude cas-témoin où des patients externes ayant nouvellement reçu un diagnostic de dépression unipolaire ont été examinés. Ceux qui ont eu une conversion de polarité à la dépression bipolaire ont été recrutés à titre de cas, et jumelés à des témoins. La validité diagnostique a été améliorée par une entrevue clinique, une revue des dossiers des cas par un psychiatre spécialiste indépendant, et l'administration de l'entrevue clinique structurée pour les troubles de l'axe I du Manuel diagnostique et statistique des troubles mentaux, 4 e édition. La régression logistique multivariée conditionnelle a été exécutée pour identifier les prédicteurs du changement à bipolaire.
Résultats : Quatre-vingt huit cas sur ceux qui ont maintenu un suivi régulier à la clinique externe (n = 823) ont présenté un changement à bipolaire durant la période à l'étude. L'incidence de la conversion de polarité était de 10,7 %. Le changement à bipolaire était associé à des antécédents familiaux de trouble affectif bipolaire, à l'utilisation de 3 différents types d'antidépresseurs ou plus dans les 5 premières années après la présentation, à la présentation des symptômes dépressifs à un âge inférieur à 37 ans, et au sexe masculin.
Conclusions : Le changement de polarité diagnostique n'est pas rare chez les patients psychiatriques externes chinois qui présentaient au départ une dépression unipolaire. Ils ont en commun certains facteurs de risque identifiés dans les études occidentales. Ceux-ci peuvent être utiles aux cliniciens comme guide pour identifier les patients souffrant de dépression à risque élevé d'évolution bipolaire.
